Artificial intelligence (AI)-assisted ultrasound in clinical trials: Endpoint automation, decentralized monitoring, and regulatory readiness

Karako K, Gao JJ

Drug Discov Ther. 2026; 20(2):91-103.

DOI: 10.5582/ddt.2026.01020

Classical traditional Chinese medicine formulas for inflammatory bowel disease: Therapeutic evidence and mechanistic insights

Yang LC, Jiang ZX, Sun Q, Yuan LW, Tang W

Drug Discov Ther. 2026; 20(2):104-118.

DOI: 10.5582/ddt.2026.01010

Modern research on formulated granules of traditional Chinese medicines and Japanese Kampo medicines: A narrative review

Li WY

Drug Discov Ther. 2026; 20(2):119-127.

DOI: 10.5582/ddt.2026.01012

Amelioration of gastrointestinal motility and gut dysbiosis by acupoint application of Tongfu Powder to loperamide-induced constipation in mice

Wang K, Cai PP, Zhao L, Wang ZX, Wang YQ, Qi FH

Drug Discov Ther. 2026; 20(2):128-146.

DOI: 10.5582/ddt.2026.01009

Cytoderm metabolic-labeling SCMLP-TB for pulmonary tuberculosis diagnosis: A preliminary diagnostic accuracy study

Liang GY, Dai GQ, Hu XR, Liu DL, Lin ZQ, Yang MR, He ZJ, Chen PF, Liu YP, Jia XY, Dai XF, Zhao PF, Zheng MB, Zhou Y, Lu HZ

Drug Discov Ther. 2026; 20(2):147-154.

DOI: 10.5582/ddt.2025.01123

Chemotherapy combined targeted therapy has a potential benefit on the survival of advanced intrahepatic cholangiocarcinoma

Yang J, Tang TQ, Liao R, He Y, Zhang H

Drug Discov Ther. 2026; 20(2):155-164.

DOI: 10.5582/ddt.2026.01007

Hypoalbuminemia and reduced sputum microbiome diversity associated with antibiotic treatment failure in nursing and healthcare-associated pneumonia

Hosogaya N, Fukui S, Takazono T, Fukushima K, Morio R, Irifune S, Morimoto S, Nakada N, Yoshida M, Takeda K, Ide S, Iwanaga N, Nemoto K, Izumikawa K, Yatera K, Yanagihara K, Mukae H

Drug Discov Ther. 2026; 20(2):165-174.

DOI: 10.5582/ddt.2026.01005

Efficacy and safety of filgotinib versus tocilizumab in active rheumatoid arthritis: A randomized, open-label, multicenter study with clinical and musculoskeletal ultrasound evaluation (TRANSFORM study)

Shimizu T, Kawashiri SY, Koga T, Kiya R, Morita M, Kawasaki R, Kuroda S, Tashiro S, Sato S, Yabe M, Misaki K, Hanai S, Nakagomi D, Ogasawara M, Tamura N, Watanabe R, Kanazawa H, Atsumi T, Ueki Y, Okano T, Suzuki T, Takaoka H, Hamada H, Hidaka T, Furuta S, Hosogaya N, Yamamoto H, Kawakami A

Drug Discov Ther. 2026; 20(2):175-189.

DOI: 10.5582/ddt.2026.01008

Effects of Janus kinase inhibition and interleukin 6 inhibition on serum cytokine/chemokine in idiopathic multicentric Castleman disease

Fukui S, Sumiyoshi R, Koga T, Hosogaya N, Narita S, Morimoto S, Kamisawa O, Kiya R, Katsube A, Yano S, Kawakami A

Drug Discov Ther. 2026; 20(2):190-198.

DOI: 10.5582/ddt.2026.01000

Trends in the prescription of constipation medications in Japan (fiscal years 2019-2023): A nationwide baseline study prior to the 2023 clinical guidelines

Tanaka H, Ishii T

Drug Discov Ther. 2026; 20(2):199-204.

DOI: 10.5582/ddt.2025.01135